March 5, 2023 — Researchers demonstrated that a causal artificial intelligence (AI) system can accurately quantify how ...
March 5, 2023 — Patients with cardiovascular disease, such as heart disease, stroke or peripheral arterial disease, were ...
March 5, 2023 — Making a connection between the flu and the risk of subsequent heart problems significantly increased ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 5, 2023 — Doctors who received customized electronic health record (EHR) alerts for specific patients were 2.5 ...
March 5, 2023 — The number of deaths and disabling strokes among patients at low surgical risk who were treated with ...
March 5, 2023 — Patients with complex coronary artery disease who underwent a stenting procedure guided by intravascular ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 5, 2023 — In patients with multi-vessel heart disease who have had a heart attack, immediate treatment with stents ...
March 5, 2023 — In patients with heart failure and a poorly functioning heart valve, a minimally invasive procedure ...
March 5, 2023 — In the largest randomized trial conducted to compare minimally invasive and conventional cardiac ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
March 4, 2023 — Of the immense volume of valuable information offered and exchanged during the first day of the American ...
March 4, 2023 — The impact of statin use to prevent heart damage during a cancer patient’s chemotherapy was in focus ...
March 4, 2023 — Findings from the TRILUMINATE Pivotal Trial found no significant difference in survival or ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
March 4, 2023 - Lexicon Pharmaceuticals, Inc. announced new analyses of results from the SOLOIST-WHF Phase 3 outcomes ...
March 4, 2023 — Viz.ai, a leader in AI-powered disease detection and care coordination, announced it will use its VizTM ...
March 4, 2023 — The cholesterol-lowering drug bempedoic acid was found to reduce the combined rate of major adverse ...